CBP, with its intrinsic HAT activity, recruits many other transcriptional co-activators to induce gene transcription, and it has been indicated that heterozygous mutation of Cbp causes cognitive disorders, including Rubinstein-Taybi syndrome, characterized by severe mental retardation [146]. The gene discussed is CREBBP; the disease is Cognitive impairment.